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Abstract: Recent trends in functional foods and supplements have demonstrated that 
bioactive molecules play a major therapeutic role in human disease. Nutritionists and 
biomedical and food scientists are working together to discover new bioactive molecules 
that have increased potency and therapeutic benefits. Marine life constitutes almost 80% of 
the world biota with thousands of bioactive compounds and secondary metabolites derived 
from marine invertebrates such as tunicates, sponges, molluscs, bryozoans, sea slugs and 
many other marine organisms. These bioactive molecules and secondary metabolites 
possess antibiotic, antiparasitic, antiviral, anti-inflammatory, antifibrotic and anticancer 
activities. They are also inhibitors or activators of critical enzymes and transcription factors, 
competitors of transporters and sequestrants that modulate various physiological pathways. 
The current review summaries the widely available marine-based nutraceuticals and recent 
research carried out for the purposes of isolation, identification and characterization of 
marine-derived bioactive compounds with various therapeutic potentials. 
Keywords: bioactive molecules; marine nutraceuticals; functional foods; supplements and 
health perspectives 
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1. Background 
The concept of “nutraceutical” was introduced by Stephen DeFelice in 1989, by combining the 
terms “nutrition” and “pharmaceutical”. The term refers to raw foods, fortified foods or dietary 
supplements containing biologically active molecules, also known as bioactive molecules [1] that 
provide health benefits beyond basic nutrition [2]. These bioactive compounds include certain 
polysaccharides, peptides, phytochemicals, vitamins, and fatty acids that are naturally present in foods, 
can be added to foods producing fortified or functional foods or can be formulated into dietary 
supplements. These bioactive molecules can be obtained either by extraction from natural sources or 
by chemical and biotechnological synthesis [3]. 
Marine ecosystems have a high diversity of living organisms compared to terrestrial ecosystems 
providing numerous resources for human nutrition and health [4]. Marine invertebrates are a diverse 
group with habitats in all ocean ecosystems, ranging from the intertidal zone to the deep sea 
environment. Organisms belonging to marine invertebrates are composed of different taxonomic 
groups, which can be classified into several major phyla, namely, Porifera (sponges), Cnidaria (corals, 
sea anemones, hydrozoans, jellyfish), Annelida (Polychaetes, marine worms), Bryozoa (moss animals 
or sea mats), Mollusca (oysters, abalone, clams, mussels, squid, cuttlefish, octopuses), Arthropoda 
(lobsters, crabs, shrimps, prawns, crayfish), and Echinodermata (sea stars, sea cucumbers, sea urchins) [5]. 
This diverse group also includes macroalgae, microalgae, bacteria, cyanobacteria, certain fish species 
and crustaceans that produce secondary metabolites as an adaptation to their hostile marine environment. 
Marine sources have received great attention recently; research on marine-derived molecules has 
discovered new bioactive compounds with important properties increasing their applicability as 
nutraceuticals in the food and supplement industries. Most notably Hippocrates, the “father of modern 
medicine”, is recorded as describing the therapeutic effects of various marine invertebrates and their 
constituents on human health [6]. Marine invertebrates account for nearly 40% of global fisheries and 
seafood obtained from these sources are highly recognized for health benefits attributed to higher 
amounts of polyunsaturated fatty acids, various peptides, minerals (selenium and iodine) and other 
bioactive compounds such as carotenoids and taurine [7]. Numerous molecules with biomedical 
functions are also supplied by marine ecosystems and are used as pharmaceuticals. 
2. Nutraceuticals in the Global Market 
The global nutraceutical market comprised of functional foods and beverages and dietary 
supplements, was valued at around $250 billion in 2014. Consumer demand for nutraceuticals is 
rapidly increasing with the market expected to reach around $385 billion by 2020 [8]. 
Nutraceutical products have a highly competitive market and price compared with conventional 
therapies; in particular their market share is increasing in many regions including the United States of 
America (USA), Europe, Japan, Asia Pacific, Middle East and Latin America. A recent analysis of the 
global industry [9] offers a detailed report of the industry structure, market drivers, trends, issues and 
competition. The global market is dominated by the USA, Europe and Japan who contribute more than 
85% of the market. It is predicted that these three regional markets will remain at the forefront of the 
nutraceutical industry both as producers and consumers due to greater product awareness, higher 
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income levels and a preference for nutraceutical products, preventive medicine and self-treatment. It is 
estimated that the Asia Pacific region, particularly China and India, will experience significant growth 
in the long term, because of increasing awareness, income and wealth. 
In the regions where nutraceutical product consumption is high, a number of dietary supplements, 
medical foods, food complements, and functional foods have invaded the food and health market with 
the aim of maintaining health and preventing disease. Within these regions, consumption rates of these 
products vary with the country, age and sex of the population. For example, consumption of 
nutraceutical products is higher in the USA [10] than any other region in the world where 
approximately 40% of adults consume nutraceutical products. In a Spanish population of 6352 males 
and females aged 35 to 80 years, 9% were consumers of dietary supplements (mainly vitamins and 
minerals). Amongst these consumers, 72% were women aged 35 to 49 years with a higher educational 
level and greater adherence to the Mediterranean diet pattern than non-consumers [11]. 
It has also been found that intake of nutraceutical products varies with lifestyle, for example 
increased physical activity and high fruit and dietary fiber intake is associated with the use of 
nutraceutical products, whereas nutraceutical product consumption decreases with obesity, smoking 
and increased intake of dietary fat [12]. Thus individuals with healthy lifestyles are more commonly 
the users of nutraceutical products. The intake of these types of products is also of special relevance 
for aging populations [13]. Elderly people are more susceptible to micronutrient deficiencies due to a 
variety of factors including social, physical, economic and emotional obstacles to eating. In response to 
the large and increasing populations of elderly individuals, there is an important need to encourage and 
maintain a healthy lifespan and prevent chronic illnesses associated with aging [14]. In the United 
Kingdom (UK) the Mintel survey on Vitamins and Minerals supplements observed that 25% of all 
adults were convinced of the benefit of the nutraceutical products and that usage varied with age; 86% 
of 55 year olds were found to use nutraceutical products compared with 65% of 20–24 year olds [15]. 
Marine nutraceutical products represent a large portion of the global market and are derived from a 
diverse range of sources that provide a myriad of bioactive molecules. These sources, as well  
as the constituent bioactive molecules, are discussed in the following sections and summarized in the 
Table 1. 
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Table 1. Marine bioactive molecules: sources, applications and health perspectives. 
Category Bioactive Molecules Applications Major Marine Sources Health Perspectives References 
Protein and 
Peptides 
Collagen 
Edible coating in meat industry  
(e.g., sausages) 
Fish (albacore tuna, silver-line grunt,  
brown-backed toadfish, hake, trout, lingcod, 
catfish, rainbow trout, yellow sea bream and 
common horse mackerel etc.). 
Anti-oxidant, anti-hypertensive and  
anti-skin-aging activities. 
[16,17] 
Gelatin 
Stabilizer, texturizer, or thickener in ice 
cream, jam, yogurt, cream cheese, 
margarine, confectionaries, utilized in 
low fat foods and clarifiers 
Fish, especially cold-water (Pollock, cod, 
haddock, hake and cusk) 
It has been shown to prevent and treat 
chronic atrophic gastritis 
[18] 
Albumin 
Whipping, suspending, or stabilizing 
agent 
Mollusks, crustaceans, low-fat fish Anticoagulant and antioxidant properties [19] 
Poly-Saccharides 
Carrageenan 
Gel formation and coatings in the meat 
and dairy industry 
Macroalgae e.g., K. alvarezii,  
E. denticulatum and B. gelatinum 
Anti-HIV activity and  
anticoagulant properties 
[20] 
Agar agar Gel formation and food gums 
Red Alga is a main source of agar agar like 
Gelidium, Gracilaria, Hypnea and Gigartina
 [21] 
Fucans and fucanoids Nutraceutical supplements 
Cell walls of brown algae, sea urchin eggs, 
sea cucumbers 
Anticoagulant, antiviral, antithrombotic, 
proliferative and anti-inflammatory 
[22] 
Chitin, chitosan, and 
derivatives 
Gelling agents, edible protective films, 
clarification and  
de-acidification of fruits 
Shrimp, crab, lobster, prawn and krill 
Increase dietary fiber, reduce lipid 
absorption, antitumor, bactericidal and 
fungicidal activities 
[23] 
Fatty acids Omega-3 fatty acids 
Nutraceuticals (fish oil and capsules), 
fortification of livestock, feed and infant 
formula 
Almost all marine sources 
Numerous health benefits (e.g., visual and 
neurodevelopment, reduce risk of 
cardiovascular problems, ameliorate 
diseases such as arthritis and hypertension) 
[24] 
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Table 1. Cont. 
Category Bioactive Molecules Applications Major Marine Sources Health Perspectives References 
Phenolic 
compounds and 
other pigments 
Phlorotannins 
Active ingredients in  
the nutraceuticals 
They are the most abundant polyphenols found 
in the marine brown algae 
Antioxidant activity [25] 
Carotenoids:  
β-carotene, and lutein 
Natural food colorings, nutraceutical 
agents, farmed salmon pigmentation 
Dunaliella salina, Sarcina maxima, 
Chlorella protothecoides, Chlorella vulgaris 
and Haematococcus pluvialis 
Vitamin A precursors, antioxidants,  
anti-carcinogenic and anti-inflammatory 
[26] 
Chlorophylls Natural food and beverage colorants S. platensis and A. flos-aquae 
Anticancer activity, natural source  
of pigmentation 
[27] 
Marine enzymes 
Gastric proteases; 
pepsins, gastricsins  
and chymosins 
Cold renneting milk and fish feed 
digestion aid 
Various fish body viscera like atlantic cod, 
carp, harp seals, and tuna etc. 
 [28] 
Serine and cysteine 
proteases 
Preventing unwanted color changes in 
food products, meat tenderizing, curing 
of Herring, squid fermentation 
Crustaceans, mollusks and short-finned squid  [28] 
Lipases 
Numerous uses in the fats and  
oils industry 
Atlantic cod, seal, salmon, sardine, Indian 
mackerel and red sea bream 
 [28] 
Transglutaminase 
Creates protein cross-links to improve 
rheological properties of gels, i.e., 
surimi, gelatin 
Red sea bream, rainbow trout, atka mackerel, 
walleye, Pollock liver and scallop 
 [29] 
Vitamins and 
Minerals 
Fat and water soluble 
vitamins, iron, iodine, 
manganese and zinc 
Food, Pharma and nutraceutical 
industries 
Almost all marine sources. Seaweeds are rich 
sources of vitamins and minerals 
Vitamins and minerals perform many 
essential functions in the body, for example, 
they provide transport inside cells and also 
serve as cofactors during metabolic processes 
[30] 
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3. Marine Sources of Bioactive Molecules 
Marine organisms represent a valuable source of bioactive compounds. The biodiversity of the 
marine environment and the associated chemical diversity constitute practically an unlimited resource 
for the development of new bioactive products [31]. Marine organisms such as sponges, tunicates, 
bryozoans, molluscs, bacteria, microalgae, macroalgae and cyanobacteria have recently been utilized 
for biotechnology. Compounds produced from these organisms are effective as therapeutics for 
infectious and non-infectious disease, with a high specificity for target molecules, usually an enzyme. 
3.1. Marine Algae 
In the nutraceutical industry marine algae are used as sources of food and food ingredients [32]. 
Microalgae and macroalgae are the two main categories of algae and both have applications  
as nutraceuticals. 
Microalgae, the most primary and simply-organized members of marine plant life, are rich sources 
of food ingredients, such as β-carotene, Vitamins C, A, E, H, B1, B2, B6 and B12, astaxanthin, 
polysaccharides and polyunsaturated fatty acids [33–35]. As such, bioactive molecules from 
microalgae are commercially produced, used as food additives and also incorporated into infant milk 
formulations and dietary supplements [36]. 
Macroalgae, also called seaweed, are the most popular type of algae in the nutraceutical industry as 
it provides a great variety of food and food ingredients especially in Asian countries like Korea,  
Japan and China [37]. It is estimated that the annual production value of macroalgae is US$5 billion in 
2007 [38,39]. Agarose is one of the main products from macroalgae, however macroalgae are also 
sources of metabolites and natural products with unique nutritional and therapeutic properties. These 
metabolites and natural products include proteins, furanone, polyunsaturated fatty acids, L-α kainic 
acid, phenotics, pigments, phlorotannins, phycocolloids (carrageenan and agar) and minerals [40]. 
Macroalgae are an important source of essential nutrients and new bioactive molecules for human 
nutrition [41]. For example, red and brown seaweeds are alternative sources of vitamins, minerals, and 
proteins [42] and are good sources of essential fatty acids [43]. They have been used to prepare 
bioactive peptides and to improve protein digestibility [44]. Recently, antihypertensive bioactive 
peptides have been isolated that may act as angiotensin-converting enzyme (ACE) inhibitors [45]. 
Macroalgae are also rich sources of insoluble and soluble dietary fiber [46] as they are not digested by 
enzymes in the gut [47] and are mainly composed of indigestible sulfated polysaccharides [43]. 
Examples of structural and storage polysaccharides found in red and brown seaweeds include fucan, 
agar, laminaran, carrageenan and alginate [48]. The alginates from brown seaweeds are utilized as 
hydrocolloids due to their biological activity [49]. Food and cosmetics industries use fucans from 
brown seaweeds. However, it is likely that all bioactive molecules from algae have not yet been 
identified and that molecules from marine algae may provide different health benefits and biological 
activities [50]. 
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3.2. Marine Fish 
Fish occupy the highest position in marine animal consumption and are important to the world 
economy. In 2012 fish provided approximately 16% of the world’s protein requirements with herring, 
salmon, cod, flounder, tuna, mullet and anchovy being the most common species of fish used for  
food [51]. One of the largest commercially canned fishery products in the world is tuna (for example, 
Thunnus Obesus). According to the Food and Agriculture Organization (FAO) of the United Nations 
(2010), the total catch of the commercial tuna species increased from 162,980 metric tons in 1950 to 
more than 4.2 million metric tons in 2007 [52]. The nutritional benefits of fish consumption are due to 
the presence of proteins, unsaturated essential fatty acids, minerals (for example, calcium, iron, 
selenium and zinc), and vitamins, namely Vitamin A, B3, B6, B12, E and D. Research has also shown 
that peptides derived from fermented fish following enzymatic treatment may be useful therapeutics 
for the treatment of many common acute and chronic diseases such as viral infections, hypertension, 
cancer and Alzheimer’s disease [53,54]. Fish collagen may also be used in bone treatment as an 
alternative to mammalian collagen which is known to be immunogenica [55]. 
3.3. Marine Invertebrates 
Marine invertebrates, like sponges, molluscs, echinoderms and crustaceans, are sources of bioactive 
peptides, steroids, terpenoids, strigolactones, alkaloids, ether and phenols [56]. Extracts or compounds 
isolated from marine invertebrates are known to include antibacterial, antiviral, anthelmintic, 
antifungal, antihypertensive, anticancer and have immune modulatory properties. A great deal of 
research has been conducted on these molecules particularly for the development of many new 
therapeutic agents [57]. 
3.4. Sponges 
Sponges are sessile metazoans that consist of a gelatinous material, mesophyl, and are the simplest 
form of multicellular animals. Their hollow pitcher-like body is reinforced by spicules (a needle-like 
silica or calcium structure) and spongia (collagen fibers) [58]. There are many chemically-diverse 
compounds like alkaloids, terpenoids, polyketides, macrolides, polyphenolic compounds, peptides and 
sterols that are isolated from sponges with the potential to cure various ailments [59]. 
3.5. Molluscs, Echinoderms and Crustaceans 
Molluscs, together with echinoderms, have been widely consumed as marine foods and are 
considered natural functional foods. Extensive research has been performed on bioactive molecules 
from these sources revealing many significant findings. Bioactive peptides obtained from the 
fermented blue mussel and oyster sauces significantly decrease hypertension [54] whilst ground 
abalone and its shells are used for treating eye diseases [51]. Many Asian populations consume 
cuttlefish, squid, octopus and nautiloids due to their therapeutic effects, for example rickets are cured 
with the bones of cuttlefish, as well as gastrointestinal disorders and ear inflammation [51]. 
Crustaceans are the biggest and most economically important class of marine arthropods in the 
global fisheries markets; they also have significant roles in nutraceutical industries [60]. In particular, 
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crabs, prawns and shrimps have gained great attention due to their effective utilization and health 
benefits [61]. Nutrient composition of marine crustaceans like shrimp and krill was analysed and found 
to decrease the total blood lipids in humans, and improve Vitamin A levels, specific proteins, and 
eicosapentaenoic acid, an omega-3 fatty acids. These are suggested to be used in the development of 
value-added health food products and for human consumption due to higher nutritional value [62].  
4. Marine Derived Bioactive Components 
Marine ecosystems provide a diverse range of bioactive molecules with extensive applications as 
nutraceuticals in the food and supplement industries. These bioactive molecules can be proteins, 
peptides, polysaccharides, fatty acids, polyphenols, probiotics, enzymes, vitamins and minerals. The 
remaining sections of this review discuss the physical and chemical properties of these different 
molecules and how they contribute bioactivity in the context of nutraceutical applications. 
4.1. Proteins 
Proteins from marine sources including fish (cod, tuna, herring, rout, hake, pollock and haddock), 
crustaceans, molluscs, extremophiles like Dunaliella, and seaweeds have unique properties such as  
gel-formation, film and foaming capacity, antioxidant, anticoagulant and antimicrobial activity.  
For example, collagen, gelatin and albumin are common marine proteins used in foods and are 
enzymatically hydrolyzed for the production of bioactive peptides which may have the potential to be 
used as nutraceuticals [54,63]. The marine protein protamine is also used as a natural antibacterial 
preservative in the food industry. 
4.2. Peptides 
Bioactive peptides are protein fragments ranging in size from 2–20 amino acid residues that may be 
generated from parent proteins during digestion or processing [64]. Two factors can influence the type 
of bioactive peptides produced: (1) the primary sequence of the protein substrate; and (2) the 
specificity of the enzyme(s) used to generate such peptides. Furthermore, bioactive peptides can be 
generated from proteins using hydrolysis (acid or alkaline), cooking or fermentation. These peptides 
have a range of bioactivities including antimicrobial, immunomodulatory, antithrombotic, and 
antihypertensive activity [65]. They are considered highly significant compounds. 
Research is being performed to understand peptide structure, composition and sequences. Bioactive 
peptides have various regulatory functions on specific cellular target formulations [66]. Many 
researchers have focused on the development of pharmaceutical compounds from marine-derived 
peptides particularly for ACE inhibition and antihypertensive function [67,68]. Marine proteins from 
fish, molluscs and crustaceans are amongst the richest sources of bioactive molecules [69]. 
Fouchereau-Peron et al. [70] reported that fish protein hydrolysates have some novel peptides that can 
bind to cell surface receptors and enhance calcium absorption. The therapeutic application of these 
peptides is the treatment of osteoporosis and Paget’s disease. Collagen is a valuable part of bovine and 
porcine meat and is used in different industries like cosmetics, pharmaceutics, food and biomedicine. 
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Meat collagen is an excellent source of bioactive peptides that function as antihypertensives and 
antithrombotics as well as inhibitors of brush border enzymes like dipeptidyl peptidase-IV [71]. 
4.3. Polysaccharides 
There are numerous commercial applications of marine polysaccharides in food, beverages and 
supplements. Marine polysaccharides, extracted from algae, crustaceans and other marine organisms 
include fucans/fucanoids, carrageenans, hydrocolloids and glycosaminoglycans. These molecules have 
many biological functions including antiviral, anticoagulant, antiproliferative, antithrombotic and  
anti-inflammatory activity [22]. Carrageenans and alginates are linear biopolymers that have been 
identified as the most abundant polysaccharides found in red and brown algae, respectively [72]. Apart 
from alginate, brown algae also contain highly complex, sulfated matrix polysaccharides called 
fucoidans. The complex structure of the fucoidans extracted from different marine species varies in 
saccharide composition, sulfate content, and positions of sulfate groups, molecular weight, linkage 
mode, and sequence of saccharide residues [73]. Structural sulfate groups improve the biological 
properties of fucoidans which enables their application as nutraceuticals in the dairy industry [74]. 
These marine-derived secondary metabolites also have many human health benefits which enable them 
to be applied as nutraceuticals. 
4.4. Fatty Acid 
Marine fish species and algae have been identified as sources of polyunsaturated fatty acids which 
are rich in ω-3 or ω-6 fatty acids. The presence of these unsaturated fatty acids in marine-derived foods 
increases their applicability as nutraceuticals in the food industry [75]. Marine-based nutraceuticals 
have many unique features not found in nutraceuticals obtained from terrestrial resources, and this is 
one of the reasons why they are gaining more attention. The most common sources of marine oils are 
fungi (Phycomycetes), fish (salmon, tuna, sardines, and herring), microalgae, extremophiles, 
macroalgae (Bryophyta, Rhodophyta) and krill. Consumption of marine oils provides numerous health 
benefits like visual and neurodevelopment, amelioration of diseases such as hypertension and arthritis 
and a reduced risk of cardiovascular problems [24]. 
4.5. Phenolic Compounds and Prebiotics 
Phenolic compounds found in marine algae are known mainly as a mechanism of adaptation for 
oxidative stress [76]. Usually phlorotannins are the most abundant polyphenols found in the marine 
brown algae whereas flavonoids contribute most to the total phenolic content in green algae. The 
brown algal phlorotannin profile mainly consists of phloroglucinol, eckol, and dieckol [76]. 
Antioxidant activity has also been reported from phlorotannins enabling these phenolic compounds to 
be used as active ingredients in nutraceuticals [25]. Similar to polyphenols, carotenoids, synthesized in 
certain marine bacteria and algal species, also have antioxidant properties which increase their 
applicability as nutraceuticals. Carotenoids are lipid-soluble, natural pigments with 40-carbon 
structures [77]. Different carotenoids are synthesized within the marine organisms, for example,  
β-carotene, astaxanthin and fucoxanthin are known to have a high antioxidant capacity. Antioxidants 
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have protective roles against excess reactive oxygen species, and also act against oxidative rancidity 
and peroxidation products like superoxide anions, hydroxyl radicals and hydrogen peroxide (H2O2) 
that cause deterioration of some foods. Currently, commercial preparation of β-carotene and 
astaxanthin is available using Dunaliella species and Haematococcus species, respectively [74]. 
Prebiotics are non-digestible, selectively-fermented compounds that stimulate the growth and 
activity of beneficial gut microbiota which, in turn, confer a health benefit to the host. Usually, 
prebiotics are oligosaccharides such as chitosan oligosaccharides, while certain other algal 
polysaccharides are also known to have a prebiotic activity [78]. Bifidogenic benefits have been also 
reported from the exopolysaccharides produced by marine lactic acid bacteria [79]. Further, the 
cyanobacterial biomass of Spirulina platensis is able to stimulate both Lactobacillus and 
Bifidobacterium species, promoting their prebiotic effect. Photosynthetic pigments are also obtained 
from red and blue-green algae, aquatic plants, microalgae and seaweed. These pigments provide 
nutraceutical agents, natural food coloring, anti-inflammatory, anticarcinogenic and antioxidant 
compounds [40]. 
4.6. Enzymes, Vitamins and Minerals 
Enzymes have the ability to change other molecules into valuable biotechnological tools that can be 
used in food and nutraceutical industries. As food ingredients, enzymes can influence factors such as 
spoilage, storage, processing and safety. Enzymes derived from marine sources are lipase, chitinolytic 
enzymes, polyphenol oxidase (Catecholase, tyrosinase, cresolase, polyphenolase, catechol oxidase, 
phendase), and transglutamase, and red algal enzymes involved in a starch degradation pathway (for 
example, α-1, 4-glucanase). They have excellent chemical, physical and/or catalytic properties 
compared with their terrestrial counterparts. They also have the ability to be inactivated at moderate 
temperatures and show high catalytic activity when the temperature is low [80]. Additionally these 
enzymes are used as food ingredients. They are used in food processing due to their salt tolerance, 
specificity, diverse properties and high activity at mild pH [81]. Biomolecules such as enzymes 
isolated from extremophiles can be highly useful in the food industry due to their unique activities 
under abnormal conditions, and it has been widely accepted that extremophiles have strong potential to 
be valuable resources for use in biotechnology [82]. 
Vitmains and minerals perform many essential functions in the body, for example, they provide 
transport inside cells and also serve as cofactors during metabolic processes. Seaweeds are rich sources 
of vitamins and minerals including iron, iodine, manganese and zinc [30]. Some types of seaweed 
could be used as natural sources of iodine [83]. 
5. Conclusions 
Marine nutraceuticals are attracting a lot of attention in the food and supplement industries. Marine 
natural products have been used as a promising source of bioactive molecules to prevent and cure 
various diseases for centuries. Accordingly, marine organisms are also one of the most important 
sources of foods with the potential to cure various ailments. Marine food provides proteins, peptides, 
polysaccharides, polyunsaturated fatty acids, vitamins, minerals and many other bioactive compounds 
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such polyphenols. The current review summarizes marine bioactive molecules and their current and 
potential utilization in food and supplement industries. 
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